IP Verse

Methods Of Treating Hepatic Encephalopathy Using Rifaximin

Patent No. EP3628319 (titled "Methods Of Treating Hepatic Encephalopathy Using Rifaximin") was filed by Salix Pharmaceuticals on Oct 2, 2009. The application was issued on Feb 14, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ACCORD HEALTHCARENov 14, 2024BRAND MURRAY FULLER
CMS CAMERON MCKENNA NABARRO OLSWANGNov 14, 2024CMS CAMERON MCKENNA NABARRO OLSWANG
HOLLATZNov 14, 2024TER MEER STEINMEISTER & PARTNER
STADA ARZNEIMITTELNov 13, 2024HAMM & WITTKOPP
TEVA PHARMACEUTICALSNov 12, 2024D YOUNG
HGFNov 4, 2024HGF

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3628319

SALIX PHARMACEUTICALS
Application Number
EP19207534A
Filing Date
Oct 2, 2009
Status
Granted And Under Opposition
Jan 12, 2024
Publication Date
Feb 14, 2024
External Links
Slate, Register , Google Patents